Literature DB >> 11794378

Iron lactate-induced osteopenia in male Sprague-Dawley rats.

S Matsushima1, M Hoshimoto, M Torii, K Ozaki, I Narama.   

Abstract

Osteopenia was induced in rats fed a diet containing 50,000 ppm (5%) iron lactate for 2 or 4 weeks. Blood chemistry, urinalysis, and bone histomorphometry of the proximal tibial metaphysis were performed. Urinary pyridinoline and deoxypyridinoline and the osteoclast number per bone surface were selected for the measurement of dynamic resorption. The osteoclast surface, eroded surface, and osteoblast surface increased at both ends of the exposure periods, and bone resorption and formation both increased. The bone volume, trabecular thickness, and trabecular number decreased, and the secondary spongiosa of proximal metaphysis showed a marked bone loss. However, no mineralization defect was observed. At the end of the 2-week exposure period, biomarkers of osteoclasts and osteoblasts had increased the most, and the osteoblast surface, osteoclast surface, and osteoclast number per bone surface increased with prolonged exposure. The pathological changes of the bone lesion in iron lactate-overloaded rats were similar to those in rats of the osteoporotic model, because they consisted of changes reflecting the increase of bone resorption and formation without an osteomalacic change. However, the decline of serum parathyroid hormone (PTH) levels was different from that of the osteoporosis model rat. We concluded iron-induced bone lesions probably differ from those of low turnover bone diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11794378     DOI: 10.1080/019262301753385951

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  7 in total

1.  Bone status in a mouse model of genetic hemochromatosis.

Authors:  P Guggenbuhl; P Fergelot; M Doyard; H Libouban; M-P Roth; Y Gallois; G Chalès; O Loréal; D Chappard
Journal:  Osteoporos Int       Date:  2010-10-26       Impact factor: 4.507

2.  Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cells.

Authors:  M Doyard; N Fatih; A Monnier; M L Island; M Aubry; P Leroyer; R Bouvet; G Chalès; J Mosser; O Loréal; P Guggenbuhl
Journal:  Osteoporos Int       Date:  2012-01-12       Impact factor: 4.507

3.  Iron excess upregulates SPNS2 mRNA levels but reduces sphingosine-1-phosphate export in human osteoblastic MG-63 cells.

Authors:  L Peltier; C Bendavid; T Cavey; M-L Island; M Doyard; P Leroyer; C Allain; M De Tayrac; M Ropert; O Loréal; P Guggenbuhl
Journal:  Osteoporos Int       Date:  2018-05-03       Impact factor: 4.507

4.  Regulation of DMT1 on Bone Microstructure in Type 2 Diabetes.

Authors:  Wei-Lin Zhang; Hong-Zheng Meng; Mao-Wei Yang
Journal:  Int J Med Sci       Date:  2015-05-26       Impact factor: 3.738

5.  Iron accumulation deteriorated bone loss in estrogen-deficient rats.

Authors:  Lu-Lin Liu; Gong-Wen Liu; Hui Liu; Kai Zhao; You-Jia Xu
Journal:  J Orthop Surg Res       Date:  2021-08-24       Impact factor: 2.359

6.  Association between bone trace elements and osteoporosis in older adults: a cross-sectional study.

Authors:  Shangjin Lin; Fengjian Yang; Ming Ling; Yongqian Fan
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-09-28       Impact factor: 3.625

7.  Decreased Bone Formation Explains Osteoporosis in a Genetic Mouse Model of Hemochromatosiss.

Authors:  Mathilde Doyard; Daniel Chappard; Patricia Leroyer; Marie-Paule Roth; Olivier Loréal; Pascal Guggenbuhl
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.